HEADER HYDROLASE/VIRAL PROTEIN 05-APR-21 7EKF TITLE STRUCTURE OF SARS-COV-2 ALPHA VARIANT SPIKE RECEPTOR-BINDING DOMAIN TITLE 2 COMPLEXED WITH HUMAN ACE2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACE-RELATED CARBOXYPEPTIDASE,ANGIOTENSIN-CONVERTING ENZYME COMPND 5 HOMOLOG,ACEH,METALLOPROTEASE MPROT15; COMPND 6 EC: 3.4.17.23,3.4.17.-; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: SPIKE PROTEIN S1; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2, UNQ868/PRO1885; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 12 ORGANISM_TAXID: 2697049; SOURCE 13 GENE: S, 2; SOURCE 14 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, SPIKE, RBD, 501Y.V1, ACE2, VIRAL PROTEIN, HYDROLASE-VIRAL KEYWDS 2 PROTEIN COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.C.HAN,C.SU,Y.F.ZHANG,J.X.QI,G.F.GAO REVDAT 2 29-NOV-23 7EKF 1 REMARK REVDAT 1 03-NOV-21 7EKF 0 JRNL AUTH P.HAN,C.SU,Y.ZHANG,C.BAI,A.ZHENG,C.QIAO,Q.WANG,S.NIU,Q.CHEN, JRNL AUTH 2 Y.ZHANG,W.LI,H.LIAO,J.LI,Z.ZHANG,H.CHO,M.YANG,X.RONG,Y.HU, JRNL AUTH 3 N.HUANG,J.YAN,Q.WANG,X.ZHAO,G.F.GAO,J.QI JRNL TITL MOLECULAR INSIGHTS INTO RECEPTOR BINDING OF RECENT EMERGING JRNL TITL 2 SARS-COV-2 VARIANTS. JRNL REF NAT COMMUN V. 12 6103 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34671049 JRNL DOI 10.1038/S41467-021-26401-W REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 30617 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1508 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.8600 - 6.3200 0.99 2828 161 0.1933 0.1839 REMARK 3 2 6.3100 - 5.0200 1.00 2709 140 0.1883 0.1917 REMARK 3 3 5.0200 - 4.3900 1.00 2679 130 0.1571 0.1475 REMARK 3 4 4.3900 - 3.9900 1.00 2647 137 0.1777 0.1874 REMARK 3 5 3.9900 - 3.7100 1.00 2625 135 0.1983 0.2387 REMARK 3 6 3.7000 - 3.4900 1.00 2597 157 0.2296 0.2799 REMARK 3 7 3.4900 - 3.3100 1.00 2630 134 0.2414 0.3073 REMARK 3 8 3.3100 - 3.1700 1.00 2588 131 0.2588 0.2917 REMARK 3 9 3.1700 - 3.0500 1.00 2615 128 0.2990 0.3759 REMARK 3 10 3.0500 - 2.9400 1.00 2623 113 0.2990 0.3244 REMARK 3 11 2.9400 - 2.8500 1.00 2568 142 0.3237 0.3856 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.402 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.153 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 69.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 6709 REMARK 3 ANGLE : 0.695 9127 REMARK 3 CHIRALITY : 0.048 970 REMARK 3 PLANARITY : 0.005 1177 REMARK 3 DIHEDRAL : 15.805 2432 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -25.2915 15.7635 -25.4044 REMARK 3 T TENSOR REMARK 3 T11: 0.4041 T22: 0.4846 REMARK 3 T33: 0.5231 T12: -0.0106 REMARK 3 T13: 0.0074 T23: -0.0305 REMARK 3 L TENSOR REMARK 3 L11: 0.6148 L22: 0.7299 REMARK 3 L33: 1.5366 L12: 0.0195 REMARK 3 L13: -0.2574 L23: 0.0965 REMARK 3 S TENSOR REMARK 3 S11: -0.0231 S12: -0.0305 S13: 0.0268 REMARK 3 S21: 0.0235 S22: 0.0576 S23: 0.1082 REMARK 3 S31: -0.0042 S32: 0.0580 S33: -0.0356 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): -32.3900 25.1285 20.9123 REMARK 3 T TENSOR REMARK 3 T11: 0.5406 T22: 0.6389 REMARK 3 T33: 0.5782 T12: 0.0197 REMARK 3 T13: 0.0305 T23: -0.0256 REMARK 3 L TENSOR REMARK 3 L11: 1.9307 L22: 1.9728 REMARK 3 L33: 2.8808 L12: -0.1314 REMARK 3 L13: -0.3594 L23: 0.0580 REMARK 3 S TENSOR REMARK 3 S11: -0.0137 S12: -0.3447 S13: 0.0773 REMARK 3 S21: 0.2693 S22: 0.0555 S23: -0.2088 REMARK 3 S31: -0.0895 S32: 0.4052 S33: -0.0486 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7EKF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-APR-21. REMARK 100 THE DEPOSITION ID IS D_1300021454. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JAN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30710 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 28.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 21.70 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.92 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6LZG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES, PH 6.5, 10% W/V PEG 5000 REMARK 280 MME, 12% V/V1-PROPANOL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 115.23500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 52.26500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 52.26500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 57.61750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 52.26500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 52.26500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 172.85250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 52.26500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 52.26500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 57.61750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 52.26500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 52.26500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 172.85250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 115.23500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 615 REMARK 465 HIS A 616 REMARK 465 HIS A 617 REMARK 465 HIS A 618 REMARK 465 HIS A 619 REMARK 465 HIS A 620 REMARK 465 HIS A 621 REMARK 465 ARG B 319 REMARK 465 VAL B 320 REMARK 465 GLN B 321 REMARK 465 PRO B 322 REMARK 465 THR B 323 REMARK 465 GLU B 324 REMARK 465 SER B 325 REMARK 465 ILE B 326 REMARK 465 VAL B 327 REMARK 465 ARG B 328 REMARK 465 PHE B 329 REMARK 465 PRO B 330 REMARK 465 ASN B 331 REMARK 465 ILE B 332 REMARK 465 LYS B 528 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 THR B 531 REMARK 465 ASN B 532 REMARK 465 LEU B 533 REMARK 465 VAL B 534 REMARK 465 LYS B 535 REMARK 465 ASN B 536 REMARK 465 LYS B 537 REMARK 465 CYS B 538 REMARK 465 VAL B 539 REMARK 465 ASN B 540 REMARK 465 PHE B 541 REMARK 465 HIS B 542 REMARK 465 HIS B 543 REMARK 465 HIS B 544 REMARK 465 HIS B 545 REMARK 465 HIS B 546 REMARK 465 HIS B 547 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PHE B 490 C PRO B 491 N 0.160 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 491 C - N - CA ANGL. DEV. = 14.4 DEGREES REMARK 500 PRO B 491 C - N - CD ANGL. DEV. = -14.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 343 30.33 -99.47 REMARK 500 ALA B 352 43.04 -109.75 REMARK 500 ASN B 370 33.91 -98.89 REMARK 500 ASN B 388 0.64 -68.44 REMARK 500 ASN B 487 18.28 59.14 REMARK 500 ALA B 522 67.82 60.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 704 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 374 NE2 REMARK 620 2 HIS A 378 NE2 83.5 REMARK 620 3 GLU A 402 OE2 87.8 94.9 REMARK 620 N 1 2 DBREF 7EKF A 19 615 UNP Q9BYF1 ACE2_HUMAN 19 615 DBREF 7EKF B 319 541 UNP P0DTC2 SPIKE_SARS2 319 541 SEQADV 7EKF HIS A 616 UNP Q9BYF1 EXPRESSION TAG SEQADV 7EKF HIS A 617 UNP Q9BYF1 EXPRESSION TAG SEQADV 7EKF HIS A 618 UNP Q9BYF1 EXPRESSION TAG SEQADV 7EKF HIS A 619 UNP Q9BYF1 EXPRESSION TAG SEQADV 7EKF HIS A 620 UNP Q9BYF1 EXPRESSION TAG SEQADV 7EKF HIS A 621 UNP Q9BYF1 EXPRESSION TAG SEQADV 7EKF TYR B 501 UNP P0DTC2 ASN 501 ENGINEERED MUTATION SEQADV 7EKF HIS B 542 UNP P0DTC2 EXPRESSION TAG SEQADV 7EKF HIS B 543 UNP P0DTC2 EXPRESSION TAG SEQADV 7EKF HIS B 544 UNP P0DTC2 EXPRESSION TAG SEQADV 7EKF HIS B 545 UNP P0DTC2 EXPRESSION TAG SEQADV 7EKF HIS B 546 UNP P0DTC2 EXPRESSION TAG SEQADV 7EKF HIS B 547 UNP P0DTC2 EXPRESSION TAG SEQRES 1 A 603 SER THR ILE GLU GLU GLN ALA LYS THR PHE LEU ASP LYS SEQRES 2 A 603 PHE ASN HIS GLU ALA GLU ASP LEU PHE TYR GLN SER SER SEQRES 3 A 603 LEU ALA SER TRP ASN TYR ASN THR ASN ILE THR GLU GLU SEQRES 4 A 603 ASN VAL GLN ASN MET ASN ASN ALA GLY ASP LYS TRP SER SEQRES 5 A 603 ALA PHE LEU LYS GLU GLN SER THR LEU ALA GLN MET TYR SEQRES 6 A 603 PRO LEU GLN GLU ILE GLN ASN LEU THR VAL LYS LEU GLN SEQRES 7 A 603 LEU GLN ALA LEU GLN GLN ASN GLY SER SER VAL LEU SER SEQRES 8 A 603 GLU ASP LYS SER LYS ARG LEU ASN THR ILE LEU ASN THR SEQRES 9 A 603 MET SER THR ILE TYR SER THR GLY LYS VAL CYS ASN PRO SEQRES 10 A 603 ASP ASN PRO GLN GLU CYS LEU LEU LEU GLU PRO GLY LEU SEQRES 11 A 603 ASN GLU ILE MET ALA ASN SER LEU ASP TYR ASN GLU ARG SEQRES 12 A 603 LEU TRP ALA TRP GLU SER TRP ARG SER GLU VAL GLY LYS SEQRES 13 A 603 GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL LEU LYS SEQRES 14 A 603 ASN GLU MET ALA ARG ALA ASN HIS TYR GLU ASP TYR GLY SEQRES 15 A 603 ASP TYR TRP ARG GLY ASP TYR GLU VAL ASN GLY VAL ASP SEQRES 16 A 603 GLY TYR ASP TYR SER ARG GLY GLN LEU ILE GLU ASP VAL SEQRES 17 A 603 GLU HIS THR PHE GLU GLU ILE LYS PRO LEU TYR GLU HIS SEQRES 18 A 603 LEU HIS ALA TYR VAL ARG ALA LYS LEU MET ASN ALA TYR SEQRES 19 A 603 PRO SER TYR ILE SER PRO ILE GLY CYS LEU PRO ALA HIS SEQRES 20 A 603 LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR ASN LEU SEQRES 21 A 603 TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO ASN ILE SEQRES 22 A 603 ASP VAL THR ASP ALA MET VAL ASP GLN ALA TRP ASP ALA SEQRES 23 A 603 GLN ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE VAL SER SEQRES 24 A 603 VAL GLY LEU PRO ASN MET THR GLN GLY PHE TRP GLU ASN SEQRES 25 A 603 SER MET LEU THR ASP PRO GLY ASN VAL GLN LYS ALA VAL SEQRES 26 A 603 CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY ASP PHE SEQRES 27 A 603 ARG ILE LEU MET CYS THR LYS VAL THR MET ASP ASP PHE SEQRES 28 A 603 LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN TYR ASP SEQRES 29 A 603 MET ALA TYR ALA ALA GLN PRO PHE LEU LEU ARG ASN GLY SEQRES 30 A 603 ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU ILE MET SEQRES 31 A 603 SER LEU SER ALA ALA THR PRO LYS HIS LEU LYS SER ILE SEQRES 32 A 603 GLY LEU LEU SER PRO ASP PHE GLN GLU ASP ASN GLU THR SEQRES 33 A 603 GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR ILE VAL SEQRES 34 A 603 GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS TRP ARG SEQRES 35 A 603 TRP MET VAL PHE LYS GLY GLU ILE PRO LYS ASP GLN TRP SEQRES 36 A 603 MET LYS LYS TRP TRP GLU MET LYS ARG GLU ILE VAL GLY SEQRES 37 A 603 VAL VAL GLU PRO VAL PRO HIS ASP GLU THR TYR CYS ASP SEQRES 38 A 603 PRO ALA SER LEU PHE HIS VAL SER ASN ASP TYR SER PHE SEQRES 39 A 603 ILE ARG TYR TYR THR ARG THR LEU TYR GLN PHE GLN PHE SEQRES 40 A 603 GLN GLU ALA LEU CYS GLN ALA ALA LYS HIS GLU GLY PRO SEQRES 41 A 603 LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU ALA GLY SEQRES 42 A 603 GLN LYS LEU PHE ASN MET LEU ARG LEU GLY LYS SER GLU SEQRES 43 A 603 PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY ALA LYS SEQRES 44 A 603 ASN MET ASN VAL ARG PRO LEU LEU ASN TYR PHE GLU PRO SEQRES 45 A 603 LEU PHE THR TRP LEU LYS ASP GLN ASN LYS ASN SER PHE SEQRES 46 A 603 VAL GLY TRP SER THR ASP TRP SER PRO TYR ALA ASP HIS SEQRES 47 A 603 HIS HIS HIS HIS HIS SEQRES 1 B 229 ARG VAL GLN PRO THR GLU SER ILE VAL ARG PHE PRO ASN SEQRES 2 B 229 ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA SEQRES 3 B 229 THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 4 B 229 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 5 B 229 SER ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER SEQRES 6 B 229 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 7 B 229 ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN SEQRES 8 B 229 ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN SEQRES 9 B 229 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 10 B 229 TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN SEQRES 11 B 229 TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU SEQRES 12 B 229 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 13 B 229 ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN SEQRES 14 B 229 CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR SEQRES 15 B 229 TYR GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 16 B 229 SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 17 B 229 PRO LYS LYS SER THR ASN LEU VAL LYS ASN LYS CYS VAL SEQRES 18 B 229 ASN PHE HIS HIS HIS HIS HIS HIS HET NAG C 1 14 HET NAG C 2 14 HET NAG A 701 14 HET NAG A 702 14 HET NAG A 703 14 HET ZN A 704 1 HET NAG A 705 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 6(C8 H15 N O6) FORMUL 7 ZN ZN 2+ HELIX 1 AA1 THR A 20 ASN A 53 1 34 HELIX 2 AA2 THR A 55 MET A 82 1 28 HELIX 3 AA3 TYR A 83 ILE A 88 5 6 HELIX 4 AA4 ASN A 90 GLN A 102 1 13 HELIX 5 AA5 ASN A 103 VAL A 107 5 5 HELIX 6 AA6 SER A 109 GLY A 130 1 22 HELIX 7 AA7 PRO A 146 SER A 155 1 10 HELIX 8 AA8 ASP A 157 VAL A 172 1 16 HELIX 9 AA9 VAL A 172 ASN A 194 1 23 HELIX 10 AB1 ASP A 198 ARG A 204 1 7 HELIX 11 AB2 GLY A 205 GLU A 208 5 4 HELIX 12 AB3 SER A 218 TYR A 252 1 35 HELIX 13 AB4 TRP A 275 ASN A 277 5 3 HELIX 14 AB5 LEU A 278 VAL A 283 1 6 HELIX 15 AB6 VAL A 293 GLN A 300 1 8 HELIX 16 AB7 ASP A 303 VAL A 318 1 16 HELIX 17 AB8 THR A 324 SER A 331 1 8 HELIX 18 AB9 THR A 365 TYR A 385 1 21 HELIX 19 AC1 PRO A 389 ARG A 393 5 5 HELIX 20 AC2 GLY A 399 ALA A 413 1 15 HELIX 21 AC3 THR A 414 ILE A 421 1 8 HELIX 22 AC4 ASP A 431 VAL A 447 1 17 HELIX 23 AC5 GLY A 448 GLY A 466 1 19 HELIX 24 AC6 PRO A 469 ASP A 471 5 3 HELIX 25 AC7 GLN A 472 ILE A 484 1 13 HELIX 26 AC8 ASP A 499 SER A 502 5 4 HELIX 27 AC9 LEU A 503 ASN A 508 1 6 HELIX 28 AD1 ILE A 513 ALA A 533 1 21 HELIX 29 AD2 PRO A 538 CYS A 542 5 5 HELIX 30 AD3 SER A 547 ARG A 559 1 13 HELIX 31 AD4 PRO A 565 GLY A 575 1 11 HELIX 32 AD5 VAL A 581 PHE A 588 1 8 HELIX 33 AD6 PHE A 588 ASN A 599 1 12 HELIX 34 AD7 LYS A 600 SER A 602 5 3 HELIX 35 AD8 PHE B 338 ASN B 343 1 6 HELIX 36 AD9 SER B 349 TRP B 353 5 5 HELIX 37 AE1 ASP B 364 ASN B 370 1 7 HELIX 38 AE2 LYS B 386 LEU B 390 5 5 HELIX 39 AE3 ASP B 405 ILE B 410 5 6 HELIX 40 AE4 GLY B 416 ASN B 422 1 7 HELIX 41 AE5 SER B 438 SER B 443 1 6 HELIX 42 AE6 GLY B 502 TYR B 505 5 4 SHEET 1 AA1 2 LYS A 131 CYS A 133 0 SHEET 2 AA1 2 CYS A 141 LEU A 143 -1 O LEU A 142 N VAL A 132 SHEET 1 AA2 2 LEU A 262 PRO A 263 0 SHEET 2 AA2 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA3 2 THR A 347 GLY A 352 0 SHEET 2 AA3 2 ASP A 355 LEU A 359 -1 O ARG A 357 N TRP A 349 SHEET 1 AA4 5 ASN B 354 ILE B 358 0 SHEET 2 AA4 5 ASN B 394 ARG B 403 -1 O VAL B 395 N ILE B 358 SHEET 3 AA4 5 PRO B 507 GLU B 516 -1 O TYR B 508 N ILE B 402 SHEET 4 AA4 5 GLY B 431 ASN B 437 -1 N ILE B 434 O VAL B 511 SHEET 5 AA4 5 THR B 376 TYR B 380 -1 N TYR B 380 O GLY B 431 SHEET 1 AA5 2 LEU B 452 ARG B 454 0 SHEET 2 AA5 2 LEU B 492 SER B 494 -1 O GLN B 493 N TYR B 453 SHEET 1 AA6 2 TYR B 473 GLN B 474 0 SHEET 2 AA6 2 CYS B 488 TYR B 489 -1 O TYR B 489 N TYR B 473 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.03 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.03 SSBOND 4 CYS B 336 CYS B 361 1555 1555 2.03 SSBOND 5 CYS B 379 CYS B 432 1555 1555 2.03 SSBOND 6 CYS B 391 CYS B 525 1555 1555 2.03 SSBOND 7 CYS B 480 CYS B 488 1555 1555 2.03 LINK ND2 ASN A 53 C1 NAG A 701 1555 1555 1.44 LINK ND2 ASN A 90 C1 NAG A 702 1555 1555 1.45 LINK ND2 ASN A 322 C1 NAG A 703 1555 1555 1.45 LINK ND2 ASN A 546 C1 NAG A 705 1555 1555 1.44 LINK ND2 ASN B 343 C1 NAG C 1 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 LINK NE2 HIS A 374 ZN ZN A 704 1555 1555 2.30 LINK NE2 HIS A 378 ZN ZN A 704 1555 1555 2.29 LINK OE2 GLU A 402 ZN ZN A 704 1555 1555 1.98 CISPEP 1 GLU A 145 PRO A 146 0 -0.19 CRYST1 104.530 104.530 230.470 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009567 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009567 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004339 0.00000